Recombinant Human Albumin (rHA) is a highly purified, non-animal-derived and alternative to plasma-derived human albumin.
- Supplement for cell culture media and tissue engineering
- Stabilizer for monoclonal antibodies, recombinant proteins, and vaccines
- Drug Formulations: Enhances drug stability, solubility, and bioavailability in injectable and topical formulations
Product application
- • Vaccine & Antibody Production: Supports stability and efficiency
- • Medical Device Coatings: Reduces immunogenicity in biomaterials
- • Diagnostics: Enhances performance and stability of diagnostic reagents
Recombinant Human Albumin (rHA) is a highly purified, non-animal-derived and alternative to plasma-derived human albumin. Lorven’s rHA is produced using advanced recombinant DNA technology in a controlled, cGMP-compliance environment, ensuring consistent quality and safety. It is designed to meet the highest quality standards for pharmaceutical, biotechnology, and research applications.
Key features & Benefits
- Animal-Free & Xeno-Free: Eliminates risks associated with blood-borne pathogens, prions, and viral contaminants.
- High Purity & Consistency: Free from plasma-derived impurities, ensuring batch-to-batch reliability.
- Enhanced Stability: Supports formulation stability in biopharmaceutical and vaccine production.
- Regulatory Compliance: Manufactured under stringent quality standards.
- Versatile Applications: Suitable for cell culture, drug delivery, regenerative medicine, and diagnostics.
Specifications
- • Expression System: Recombinant yeast (Pichia Pastoris)
- • Purity: > 99%
- • Molecular Weight: ~66.5 kDa
- • Endotoxin Level: < 0.1 EU/mg
- • Format: Lyophilized powder / Liquid
- • Storage Conditions: 2°C - 8°C (lyophilized), -20°C (liquid)
Packaging and Bulk Availability
- Available in a variety of packaging sizes to meet industrial and research needs. Custom formulations and bulk supply options available upon request.
Our trusted partners
